ROCHELLE SATERI: Open Payments
NPI 1518020312 · GALLOWAY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,089 in 22 payments from 11 companies in 2025. Trend: 2023 $1,118 · 2024 $1,062 · 2025 $1,089
Food & beverage: $1,089
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $286 |
| AstraZeneca Pharmaceuticals LP | 4 | $152 |
| BridgeBio Pharma, Inc. | 1 | $135 |
| Alnylam Pharmaceuticals Inc. | 1 | $122 |
| Novo Nordisk Inc | 1 | $108 |
| Neurocrine BioSciences, Inc. | 1 | $103 |
| E.R. Squibb & Sons, L.L.C. | 1 | $67 |
| Hologic Sales and Service, LLC | 2 | $34 |
| SCPHARMACEUTICALS INC. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 2 | $29 |
Products named: LifeVest, Attruby, AMVUTTRA, Ozempic, INGREZZA, CAMZYOS, FARXIGA, NOVASURE.
Industry payments across NJ — which companies pay providers there.
